MediCell Technologies

Focus: MediCell Technologies is a stem cell biotechnology company focused on cell therapy treatments, headquartered in Carlsbad, CA. The company is advancing regenerative medicine solutions with a current pipeline centered on aesthetic and therapeutic applications.

Cell Therapy

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About MediCell Technologies

AI assessmentNot Hiring

No open roles listed right now. Follow MediCell Technologies to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

1 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

DefenAge 8-in-1 BioSerum

Periorbital Wrinkles

Growth

Only active commercial asset; Phase 3 status suggests pathway toward market entry, though aesthetic indication limits systemic revenue ceiling.

Pipeline & Clinical Trials

Help build intelligence for MediCell Technologies

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work in the high-growth stem cell and cell therapy space, a frontier area with significant unmet clinical need and commercial potential
Involvement in Phase 3 development of DefenAge, positioning you near potential regulatory milestones and market launch activities
Exposure to an emerging therapeutic modality (cell therapy) that offers differentiation from traditional small-molecule and biologic approaches

Watch Out For

No current active job openings (activeJobCount = 0) suggests limited immediate hiring or potential organizational constraints
Sparse public data on financials, funding, employee count, and clinical progress limits visibility into company stability and growth trajectory
Single-program pipeline with only one Phase 3 trial indicates high execution risk if this program encounters setbacks

Generated by Claude from MediCell Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

enhanced DefenAge 8-in-1 BioSerum

Periorbital Wrinkles

Phase 3

Clinical Trials (1)

NCT05082766Improvement in the Appearance of Periorbital Wrinkles

Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo